The Slack-backed enterprise video messaging platform took its total funding to $45m with a Sequoia-led round that will fund product development.

NetEase has led a series B round for the game developer reportedly sized at up to $30m and will now help it expand into China.

JMDC, Gene Techno Science, Astellas Venture Management and Nissay Capital have contributed to a $25.8m round for Keio University's heart failure treatment developer.

V2Food has secured series A funding on the back of its strategic partnership with burger retail chain Hungry Jack's.

Asset data and management software provider Lixiangjia has raised series D-plus funding having reportedly already begun IPO preparations.

JMDC, Gene Techno Science, Astellas Venture Management and Nissay Capital contributed to a $25.8m round for the heart failure treatment developer.

Novartis, Bayer, Evotec, Merck Group and Alexandria Real Estate Equities all invested in Longwood Fund-founded cancer immunotherapy startup Immunitas Therapeutics.

IIH Healthcare was among the investors in a series A round raised as Lucence prepares to launch its first precision medicine screening test for cancer.

Akatsuki, Dentsu, GMO Internet and Nippon Broadcasting System chipped in as the livestreaming platform raised $28.6m in a round in which DeNA sold some of its shares.

The e-commerce firm has agreed to pay approximately $21m for a 30% stake in Mengniu Dairy's delivery service spinoff, in a deal set to close by the end of next year.